HAYWARD, Calif., Oct. 18, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, will release its third quarter 2012 financial report after market close on Wednesday, October 24, 2012. Anthera will host a conference call at 1:00 pm Eastern Time on Thursday, October 25, 2012. Conference Call Access:Date: Thursday, October 25, 2012Time: 1:00 pm Eastern Time Domestic Dial-in: (877) 312-8807International Dial-in: (253) 237-1190Conference ID: 44939072 To access the 24-hour audio replay, U.S. and Canadian participants may dial (855) 859-2056; international participants may dial (404) 537-3406. The conference ID for the replay is 44939072. The audio replay will be available until November 1, 2012. About Anthera Pharmaceuticals Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases. CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., firstname.lastname@example.org or 510-856-5586. SOURCE Anthera Pharmaceuticals, Inc.